Metronidazole Benzoate
»Metronidazole Benzoate contains not less than 98.5percent and not more than 101.0percent of C13H13N3O4,calculated on the dried basis.
Packaging and storage
Preserve in well-closed,light-resistant containers.Store at 25,excursions permitted between 15and 30.
Identification
B:
The principal spot in the chromatogram of the Test solutioncorresponds to that in the chromatogram of Standard solution A,as obtained in the test for Related compounds.
Acidity
Neutralize 40mLof a mixture of dimethylformamide and water (1:1)with hydrochloric acid or 0.02Msodium hydroxide,add 0.2mLof methyl red TSand 2.0g of Metronidazole Benzoate,mix to dissolve,and titrate with 0.02Msodium hydroxide:not more than 0.25mLis required to produce a color change.
Loss on drying á731ñ
Dry it at 80for 3hours:it loses not more than 0.5%of its weight.
Residue on ignition á281ñ:
not more than 0.1%.
Heavy metals,Method IIá231ñ:
0.002%.
Related compounds
Adsorbent:
0.2-mm layer of chromatographic silica gel mixture.
Test solution
Transfer about 200mg of Metronidazole Benzoate,accurately weighed,to a 10-mLvolumetric flask,dissolve in and dilute with acetone to volume,and mix.
Standard solution A
Dissolve an accurately weighed quantity of USP Metronidazole Benzoate RSin acetone,and dilute quantitatively,and stepwise if necessary,with acetone to obtain a solution having a known concentration of about 0.1mg per mL.
Standard solution B
Transfer 4.0mLof Standard solution Ato a 10-mLvolumetric flask,dilute with acetone to volume,and mix.
Standard solution C
Transfer about 10mg each of metronidazole and 2-methyl-5-nitroimidazole,accurately weighed,to a 50-mLvolumetric flask,dissolve in and dilute with acetone to volume,and mix.
Application volume:
10µL.
Developing solvent system:
ethyl acetate.
Procedure
Proceed as directed for Thin-Layer Chromatographyunder Chromatography á621ñ.Examine the plate under short-wavelength UVlight:the test is valid only if the metronidazole and 2-methyl-5-nitroimidazole spots obtained from Standard solution Care clearly separated;no spot obtained from the Test solutionis larger or more intense than the principal spot obtained from Standard solution A(0.5%);and not more than three spots,excluding the principal spot,obtained from the Test solutionare larger or more intense than the principal spot obtained from Standard solution B(1.0%).
Organic volatile impurities,Method IVá467ñ:
meets the requirements.
Assay
Transfer about 250mg of Metronidazole Benzoate,accurately weighed,to a suitable container,and dissolve with stirring in 50.0mLof glacial acetic acid.Titrate with 0.1Nperchloric acid,determining the endpoint potentiometrically.Perform a blank determination,and make any necessary correction (see Titrimetry á541ñ).Each mLof 0.1Nperchloric acid is equivalent to 27.53mg of C13H13N3O4.
Auxiliary Information
Staff Liaison:Behnam Davani,Ph.D.,MBA,Senior Scientist
Expert Committee:(PA7)Pharmaceutical Analysis 7
USP28NF23Page 1286
Pharmacopeial Forum:Volume No.29(5)Page 1537
Phone Number:1-301-816-8394
|